Xcellerant Ventures

DeepLook Medical is a developer of advanced medical imaging software focused on enhancing the early detection of breast cancer through mammograms. The company's technology employs shape-recognition software to analyze radiological images, particularly those of dense breast tissue, uncovering subtle data that is often difficult for human eyes to discern. By revealing unique radiomic features that reflect tissue morphology, DeepLook Medical's software aids physicians in reducing false positives, thereby minimizing unnecessary surgical procedures. Additionally, the company maintains a phenotype database of breast cancer morphology, which is available for research purposes, contributing to the advancement of breast cancer detection and treatment methodologies.

CRISPRQC develops an analytics platform that enhances the efficiency and effectiveness of CRISPR gene editing. This platform is built around the CRISPR-Chip, a unique device that directly measures CRISPR activity. By simulating the gene editing process prior to cell introduction, CRISPRQC provides essential data and insights that are crucial for quality control and maximizing the potential of CRISPR technology. The platform empowers scientists to increase editing efficiency and formulate strategies for improved outcomes at the cellular level, ultimately accelerating the development of CRISPR-based products.

Lenoss Medical is a company focused on developing innovative solutions for the treatment of spinal fractures. Their primary offering is the osteopearl VBA system, a minimally invasive technology that promotes natural osseous healing without the use of cement. By harnessing the inherent healing properties of healthy bone, Lenoss Medical aims to provide effective treatment options for osteoporotic patients, minimizing the risk of complications often associated with traditional methods. The company is dedicated to improving patient outcomes in spinal care through its advanced medical instruments and techniques.

TruLite Health is a health equity platform focused on addressing disparities in healthcare delivery and outcomes. The company offers a comprehensive enterprise point-of-care software-as-a-service (SaaS) solution that integrates a proprietary clinical knowledge base with patient-specific clinical and social data. By doing so, TruLite Health empowers care teams to implement actionable interventions tailored to diverse populations, thus enhancing clinical, social, and behavioral support. Its innovative approach aims to close the health equity gap, ultimately contributing to improved health outcomes for patients and communities.